2-(3-(Quinolin-6-yl)propanamido)cyclohex-1-enecarboxylic acid

ID: ALA3297873

Chembl Id: CHEMBL3297873

PubChem CID: 90682801

Max Phase: Preclinical

Molecular Formula: C19H20N2O3

Molecular Weight: 324.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCc1ccc2ncccc2c1)NC1=C(C(=O)O)CCCC1

Standard InChI:  InChI=1S/C19H20N2O3/c22-18(21-17-6-2-1-5-15(17)19(23)24)10-8-13-7-9-16-14(12-13)4-3-11-20-16/h3-4,7,9,11-12H,1-2,5-6,8,10H2,(H,21,22)(H,23,24)

Standard InChI Key:  KHTVMFJCMFWFBJ-UHFFFAOYSA-N

Associated Targets(Human)

HCAR1 Tchem G-protein coupled receptor 81 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR3 Tchem HM74 nicotinic acid GPCR (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 324.38Molecular Weight (Monoisotopic): 324.1474AlogP: 3.20#Rotatable Bonds: 5
Polar Surface Area: 79.29Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.41CX Basic pKa: 4.51CX LogP: 1.42CX LogD: -0.83
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.88Np Likeness Score: -0.57

References

1. Bobileva O, Bokaldere R, Gailite V, Kaula I, Ikaunieks M, Duburs G, Petrovska R, Mandrika I, Klovins J, Loza E..  (2014)  Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.,  22  (14): [PMID:24864041] [10.1016/j.bmc.2014.05.011]

Source